In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis

被引：19

作者：

Schmitz, FJ

Schwarz, S

Milatovic, D

Verhoef, J

Fluit, AC

机构：

[1] Univ Dusseldorf, Inst Med Microbiol & Virol, D-40225 Dusseldorf, Germany

[2] Eijkman Winkler Inst Med Microbiol, Utrecht, Netherlands

[3] Bundesforschungsanstalt Landwirtschaft, Inst Tierzucht & Tierverhalten, Celle, Germany

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2002年 / 50卷 / 01期

关键词：

D O I：

10.1093/jac/dkf085

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：145 / 148

页数：4

共 50 条

[1] In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
Brueggemann, AB
Doern, GV
Huynh, HK
Wingert, EM
Rhomberg, PR
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) : 447 - 449
[2] In vitro activity of telithromycin compared with macrolides and fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis
Küçükbasmaci, O
Gönüllü, N
Aktas, Z
Gürol, D
Berkiten, R
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 22 (05) : 497 - 501
[3] In Vitro Activity of Delafloxacin Tested against Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
Flamm, Robert K.
Rhomberg, Paul R.
Huband, Michael D.
Farrell, David J.
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (10) : 6381 - 6385
[4] In vitro bactericidal activity of ABT-773 versus four other agents against Streptococcus pneumoniae and Haemophilus influenzae
Neuhauser, MM
Jung, R
Danziger, LH
Pendland, SL
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (05) : 395 - 398
[5] Postantibiotic effects of ABT-773 and amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae
Neuhauser, MM
Prause, JL
Danziger, LH
Pendland, SL
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) : 3613 - 3615
[6] In vitro activities of cethromycin (ABT-773), a new ketolide, against Streptococcus pneumoniae strains that are not susceptible to penicillin or macrolides
Mason, WO
Lamberth, LB
Wald, ER
Bradley, JS
Barson, WJ
Kaplan, SL
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) : 166 - 169
[7] In vitro bactericidal activities of ABT-773 against ermB strains of Streptococcus pneumoniae
Neuhauser, MM
Prause, JL
Danziger, LH
Pendland, SL
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (03) : 1132 - 1134
[8] Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae
Walsh, F
Carnegy, F
Willcock, J
Amyes, S
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (05) : 793 - 796
[9] Activities of faropenem, an oral β-lactam, against recent US isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
Critchley, IA
Karlowsky, JA
Draghi, DC
Jones, ME
Thornsberry, C
Murfitt, K
Sahm, DF
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (02) : 550 - 555
[10] In vitro pharmacodynamic activities of ABT-492, a novel quinolone, compared to those of Levofloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
Gunderson, SM
Hayes, RA
Quinn, JP
Danziger, LH
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) : 203 - 208

← 1 2 3 4 5 →